UK markets closed
NIKKEI 225
38,236.07 -38.03 (-0.10%) HANG SENG
18,475.92 +268.82 (+1.48%) CRUDE OIL
78.56 +0.45 (+0.58%) GOLD FUTURES
2,312.90 +4.30 (+0.19%) DOW
38,675.68 +449.98 (+1.18%) Bitcoin GBP
51,240.69 +682.65 (+1.35%)
Amneal Pharmaceuticals, Inc. (2DT.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:29PM CEST
| Previous close | 5.65 |
| Open | 5.70 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 5.70 - 5.75 |
| 52-week range | 1.60 - 5.75 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 1.944B |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.46 |
| Earnings date | 29 Feb 2024 - 04 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.33 |
- GuruFocus.com
Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Amneal Pharmaceuticals reports significant revenue and EBITDA growth in Q1 2024, driven by new product launches and strong market performance.
Business WireAmneal Reports First Quarter 2024 Financial Results
BRIDGEWATER, N.J., May 03, 2024--AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Business WireAmneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
BRIDGEWATER, N.J., April 24, 2024--Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose
© 2024 Yahoo. All rights reserved.